Clinical trial in a test tube for medical countermeasure development

Ended Definitive Contract Awarded Last action

Contract number
HHSO100201000035C
Awardee
Awarding agency
Obligated
$16,925,701

Award facts

Contract value 64% obligated
  • $16,925,701.24 Current, with exercised options
  • $26,547,053.24 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 6 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Orlando, FL 32826, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00016 -$14,408
Funding Only Action P00015 · The purpose of this modification is to provide funding to cover indirect rates adjustment for FY15 and FY16 in support of the clinical trial in a test tube… $240,765
Other Administrative Action 14 · The purpose of this modification is to deobligate $398,471.28 as part of closeout procedures. -$393,471
Other Administrative Action 13 · Extend the end date of the contract to 1/31/16 at no additional cost. $0
Other Administrative Action 12 · Revised SOW incorporate changes to option 2. There will be no additional cost and the period of performance is extended to 10/31/2015. $0
Other Administrative Action 11 $0
Other Administrative Action 10 · Revised SOW to begin work on the laboratory portion of the option following a delayed meeting with the FDA. There will be no additional cost and the period of… $0
Exercise an Option 9 $5,274,460
Other Administrative Action 8 · No cost extension to facilitate the time needed to complete modification to exercise option $0
Other Administrative Action 7 · No cost extension to the vaxdesign contract to allow for more adminstrative time to execute the option. $0
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Exercise an Option 4 $4,352,750
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Other Administrative Action 3 · Clinical trial in a test tube for miedical countermeasure development $0
Original award $7,465,605
Show all 17

About this award

The Office of the Assistant Secretary for Preparedness and Response awarded a $26.5 million definitive contract to Sanofi Pasteur Vaxdesign Corp. for clinical trial in a test tube for medical countermeasure development on July 30, 2010, under firm fixed price.

Place of performance is Orlando, FL. The contract ceiling value is $26,547,053.24, with an ultimate completion date of September 29, 2020.

Quick answers

Who was awarded contract HHSO100201000035C?

HHSO100201000035C was awarded to Sanofi Pasteur Vaxdesign Corp by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on July 30, 2010.

How much is contract HHSO100201000035C worth?

The government has obligated $16,925,701 on HHSO100201000035C. Its potential value, with all options, is $26,547,053.

Was contract HHSO100201000035C competed?

The extent of competition for HHSO100201000035C was full and open competition. The government received 6 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award